Gene Query: CBL

Dataset Description Geneva Score
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 47.71
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 47.23
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 47.23
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 36.36
RNA sequencing of mechanically strained NHEKs and control NHEKs 35.75
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 34.41
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 30.59
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 30.59
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 28.39
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 26.76
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 25.61
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 23.1
miRNAs affected by antagomiR-17 treatment 23.04
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 21.99
RNAseq Analysis in glioblastoma cells treated with Mepazine 21.98
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 21.86
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 21.86
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 21.05
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 20.91
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 20.78
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 20.78
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 20.41
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 20.33
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 19.94
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 19.84
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 19.16
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 18.78
Selective suppression of endothelial cytokine production by progesterone receptor 18.78
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 18.31
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 18.15
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 17.99
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 17.98
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 17.97
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 17.9
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 17.9
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 17.72
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 17.72
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 17.61
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 17.51
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 17.34
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 17.19
Ebola virus (EBOV) infection of ARPE-19 cells 17.0
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 16.94
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 16.91
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 16.8
Knockdown of ADNP in HCT116 colon cancer cells 16.65
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 16.14
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 15.98
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 15.95
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 15.9
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 15.9
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 15.41
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 15.33
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 15.07
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 15.03
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 14.65
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 14.58
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 14.56
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 14.41
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 14.41
RNA sequencing of GlyH-101-treated MCF-7 cell line 14.31
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 14.25
Identifying the molecular mode of action of itraconazole in colorectal cancer 14.19
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 14.18
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 14.12
Human neutrophil genome during PMA- and E. coli encounter-induced activation 14.1
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 14.1
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 13.99
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 13.8
RNA-seq of naive and primed ES cells 13.76
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 13.55
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 13.54
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 13.53
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 13.51
RNA-seq of young and quiescent MRC-5 human fibroblasts 13.51
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 13.44
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 13.43
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 13.19
The interplay between SOX4 and SMAD3 in the context of breast cancer 13.17
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 13.17
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 13.14
Tracing Enhancer Networks using Epigenetic Traits (TENET) 12.98
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 12.77
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 12.66
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 12.64
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 12.54
Modeling CADASIL vascular pathologies with patient-derived induced pluripotent stem cells 12.44
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 12.33
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.32
Genetic-to-epigenetic Therapy for Pancreatic Cancer 12.2
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 12.16
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 12.16
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 11.97
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 11.96
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 11.96
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 11.92
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 11.9
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 11.85
An siRNA screen identifies CHD4 as a target for epigenetic therapy 11.84
Impact of dieldrin on transcription in Jurkat T cells 11.79
RNAseq analysis of ESRP regulated splicing events in prostate cancer 11.73
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 11.72
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 11.66
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 11.65
Human HAP1 cells before and after nutrient deprivation 11.55
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 11.55
Pharmacologic inhibition of STAT5 in AML 11.41
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 11.36
LIN28A modulates splicing and gene expression programs in breast cancer cells 11.3
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 11.3
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 11.25
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 11.25
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 11.24
Patient-derived luminal breast cancer xenografts with progestins 11.24
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 11.24
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 11.2
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 11.15
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 11.1
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 11.1
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 11.04
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 11.04
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 11.03
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 11.01
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 11.01
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 10.99
AMPK signaling for naïve pluripotency 10.94
AMPK signaling for naïve pluripotency [Hs] 10.94
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 10.94
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 10.93
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 10.91
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 10.89
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 10.86
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 10.84
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 10.84
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 10.83
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 10.74
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 10.7
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 10.61
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 10.56
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 10.56
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 10.45
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 10.44
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 10.43
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 10.43
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 10.42
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 10.4
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 10.35
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 10.34
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition [RNA-Seq] 10.25
Krüppel-like Transcription Factor-10 (KLF10) Provides a Negative Feedback Mechanism to Suppress TGFβ-Induced Epithelial-to-Mesenchymal Transition 10.25
N6-methyladenine DNA Modification in Glioblastoma 10.19
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 10.19
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 10.18
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 10.18
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 10.08
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 10.05
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 9.99
Total RNA-seq in ALL-SIL upon TLX1 knockdown 9.98
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 9.98
Cerebellar differentiation in Ataxia-Telangiectasia 9.96
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 9.94
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 9.94
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 9.9
Organoids derived from directly reprogrammed human hepatocytes for modeling liver cancer initiation 9.89
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 9.76
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 9.75
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 9.75
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 9.71
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 9.71
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 9.71
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 9.69
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 9.69
MYCi361 regulates MYC target genes 9.65
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 9.61
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.6
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 9.56
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 9.52
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 9.51
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 9.5
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 9.47
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 9.43
Gene expression analysis upon mtDNA depletion 9.31
Gene expression analysis upon mtDNA depletion [RNA-seq] 9.31
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 9.26
Landscape and variation of RNA secondary structure across the human transcriptome 9.24
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 9.22
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 9.22
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 9.16
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 9.14
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.11
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 9.11
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 9.1
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 9.09
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 9.08
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 9.04
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 9.02
Effect of PBK knockdown on C4-2 cell transcriptome 9.01
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 8.99
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 8.9
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.88
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 8.86
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 8.84
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 8.82
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 8.78
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 8.74
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 8.73
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 8.73
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 8.72
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 8.71
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 8.71
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 8.7
Active translatome profiling with RiboLace in MCF7 cells 8.68
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 8.67
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 8.66
Transcriptome analysis of CNS leukemia 8.66
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 8.66
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.64
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 8.64
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 8.62
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 8.57
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 8.56
Stem and effector CD8 T-cells from human cancers 8.54
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.53
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 8.48
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 8.44
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 8.44
Generation and persistence of human tissue-resident memory T cells in lung transplantation 8.42
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 8.31
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 8.28
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.25
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 8.23
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 8.13
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 8.12
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 8.12
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 8.09
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 8.07
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 7.96
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 7.87
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 7.84
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 7.84
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 7.83
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.83
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 7.74
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 7.7
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 7.65
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 7.6
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 7.59
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 7.53
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.53
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 7.41
EGR1-controlled transcriptome of T HESCs 7.4
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 7.38
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 7.33
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 7.3
Hypoxic transcriptome of SQ20B human head and neck cancer cells 7.27
Searching for target genes of miR-508/509/506/514 in HCT116 cells 7.25
LncRNA expression profiling of ischemic stroke patients 7.24
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 7.23
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 7.21
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 7.16
Induced DNA demethylation, genome instability and transcription 7.16
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 7.15
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 7.15
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 7.11
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 7.09
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 7.05
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 7.05
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 7.03
Gene expression changes after LOC550643 silencing 7.01
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 6.94
The cohesin release factor WAPL restricts chromatin loop extension. 6.93
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 6.93
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 6.93
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 6.89
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 6.78
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 6.72
Transcriptomes of human monocytes after ex vivo exposure to uric acid 6.64
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 6.63
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 6.61
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.57
The comparison of high-throughput single-cell RNA-seq methods 6.53
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 6.53
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 6.52
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.52
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 6.43
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 6.41
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.41
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 6.34
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 6.34
Gene expressions of H9s in different culture systems 6.32
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.32
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.31
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 6.3
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 6.28
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 6.23
RNA-seq of naive and primed ES cells (NHSM) 6.21
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 6.2
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 6.19
naive T cell heterogeneity after neonatal thymectomy 6.13
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 6.04
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells 6.01
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 5.99
Anti-inflammatory effect of indoleacrylic acid (IA) 5.98
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 5.98
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 5.96
RNA-Seq of human induced pluripotent stem cell-derived cardiomyocytes from a cardiomyopathy patient and familial control 5.93
KLF6-dependent transcription in renal cancer cells 5.9
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 5.8
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.71
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 5.71
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 5.69
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 5.69
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 5.62
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 5.57
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 5.56
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 5.54
Effect of BMP inhibition or stimulation of primary human keratinocytes 5.52
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 5.52
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 5.52
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 5.52
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 5.49
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 5.48
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 5.47
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 5.47
Generation of KRAS signatures using immortalized isogenic lung cells. 5.36
NAPRT activation of macrophages 5.31
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.29
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  5.28
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 5.25
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 5.17
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 5.08
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 5.06
RNA-seq of RKO cells with cTAZ KO or putback 5.03
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.0
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.98
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 4.72
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 4.69
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 4.69
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.63
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.62
Solid phase chemistry to covalently and reversibly capture thiolated RNA 4.62
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 4.4
MARCKS and lnc-MARCKS act as inflammation regulators 4.39
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 4.36
Transcriptome analysis of peripheral blood monocytes 4.35
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.28
Dissecting neural differentiation regulatory networks through epigenetic footprinting 4.25
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 4.24
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 4.22
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 4.22
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 4.17
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 4.14
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 4.09
CD74 role in transcription regulation 4.09
CD74 role in transcription regulation [RNA-seq] 4.09
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 4.0
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 3.91
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.85
STRIPAK directs PP2A activity to promote oncogenic transformation 3.81
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.73
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 3.71
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 3.71
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 3.7
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 3.65
Molecular Criteria for Defining the Naive Human Pluripotent State 3.61
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.52
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.52
Transcriptome analysis of SKI knock-out in HL60 cells 3.51
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 3.51
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 3.5
miR-93 Targets in Human Endothelial Cells 3.47
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 3.46
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 3.42
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 3.42
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 3.4
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.36
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 3.33
Effects of transcription on genome - nuclear lamina interactions 3.33
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 3.32
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 3.32
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.31
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.26
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.26
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 3.12
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 3.03
Copper Regulation of HIF-1 Transcription Activity 2.94
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 2.94
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 2.93
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.87
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.87
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.86
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 2.83
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 2.77
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.74
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 2.73
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.72
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.71
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 2.7
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 2.7
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 2.7
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.69
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 2.69
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 2.68
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.68
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.66
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 2.59
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 2.57
Frailty in middle age is associated with race-specific changes to the transcriptome. 2.53
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.52
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 2.5
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 2.5
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 2.48
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 2.45
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.41
Generation and functional characterization of MDSC-like cells 2.37
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 2.27
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.2
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.19
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 2.17
Transcriptomes in healthy and CHB fetal hearts 2.09
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.08
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 2.06
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 2.06
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 2.03
A Unique Epigenomic Landscape Defines Human Erythropoiesis 2.03
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.91
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 1.86
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 1.86
Aneuploidy triggers an immune response 1.84
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.83
Identification of differentially expressed genes between senescence and senescence bypass cells 1.81
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.78
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.77
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.77
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.77
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.77
AUF-1 affected genes in human skin cells 1.76
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 1.71
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.71
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.64
The role of the Calcium-Sensing receptor in colorectal cancer 1.63
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 1.61
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 1.58
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 1.57
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 1.57
MYCL and EP400 are required for Max and MCPyV mediated gene activation 1.54
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.53
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.46
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.3
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.3
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.26
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 1.26
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 1.18
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 1.12
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.08
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.08
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.07
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.05
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.02
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 1.02
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 0.99
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 0.99
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.96
Expression analysis of the TAF1 syndrome 0.95
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 0.95
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.88
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.86
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.85
Gene expression changes due to PARP knockdown in human cells 0.81
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.8
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.79
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.7
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.7
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.64
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.62
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.59
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.53
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.49
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 0.4
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.37
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.37
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 0.35
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.32
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.27
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.25
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.25
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.24
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.24
Truncation of LOC100288798 (SLC38A4-AS) lncRNA in human haploid KBM7 cell line 0.22
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.21
In situ CAPTURE of chromatin interactions by biotinylated dCas9 0.2
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 0.2
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.18
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 0.15
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.14
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.13
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.11
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.09
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 0.06
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation